CCEL Key Statistics, Chart & Performance
The current stock price of CCEL is 3.49 USD. In the past month the price decreased by -18.84%. In the past year, price decreased by -54.17%.
CCEL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.68 | 101.58B | ||
| CI | THE CIGNA GROUP | 9.72 | 73.73B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 125.15 | 23.02B | ||
| LH | LABCORP HOLDINGS INC | 15.99 | 20.97B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.98 | 19.52B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.06B | ||
| DVA | DAVITA INC | 12.3 | 8.01B | ||
| HIMS | HIMS & HERS HEALTH INC | 63.15 | 7.76B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 37.1 | 6.82B | ||
| CHE | CHEMED CORP | 19.75 | 6.15B | ||
| RDNT | RADNET INC | 191.61 | 5.62B | ||
| OPCH | OPTION CARE HEALTH INC | 21.6 | 5.11B |
Related stock screener links
About CCEL
Company Profile
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Company Info
CRYO-CELL INTL INC
700 Brooker Creek Blvd, Suite 1800
Oldsmar FLORIDA US
CEO: David Portnoy
Employees: 84
Phone: 18137492104
CRYO-CELL INTL INC / CCEL FAQ
What does CCEL do?
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Can you provide the latest stock price for CRYO-CELL INTL INC?
The current stock price of CCEL is 3.49 USD. The price decreased by -0.29% in the last trading session.
What is the dividend status of CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a dividend yield of 25.13%. The yearly dividend amount is currently 0.25.
What is the ChartMill technical and fundamental rating of CCEL stock?
CCEL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is CRYO-CELL INTL INC (CCEL) stock traded?
CCEL stock is listed on the NYSE Arca exchange.
What is the analyst forecast for CCEL stock?
6 analysts have analysed CCEL and the average price target is 8.67 USD. This implies a price increase of 148.42% is expected in the next year compared to the current price of 3.49.
What sector and industry does CRYO-CELL INTL INC belong to?
CRYO-CELL INTL INC (CCEL) operates in the Health Care sector and the Health Care Providers & Services industry.
CCEL Technical Analysis
CCEL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CCEL. CCEL has a medium profitability rating, but doesn't score so well on its financial health evaluation.
CCEL Financial Highlights
Over the last trailing twelve months CCEL reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 94.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.75% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CCEL Forecast & Estimates
6 analysts have analysed CCEL and the average price target is 8.67 USD. This implies a price increase of 148.42% is expected in the next year compared to the current price of 3.49.
For the next year, analysts expect an EPS growth of 87% and a revenue growth -1.55% for CCEL